Table 3 Median and 95% credible intervals for all model parameters for each treatment group

From: Modelling microbiome recovery after antibiotics using a stability landscape framework

  

D

A

Phi1

Phi2

Microbiome

Antibiotic

Median

95% CI

Median

95% CI

Median

95% CI

Median

95% CI

Gut

Ciprofloxacin

7.9

(5.47 to 9.75)

0.8

(0.28 to 1.34)

−0.2

(−0.69 to 0.16)

0.41

(0.05 to 0.92)

Clindamycin

8.45

(6.23 to 9.84)

0.84

(0.29 to 1.42)

0

(−0.46 to 0.34)

0.56

(0.23 to 1.11)

Amoxicillin

1.34

(0.13 to 6.56)

−0.03

(−0.66 to 0.56)

−1.53

(−1.96 to 0.31)

0.09

(−1.58 to 1.83)

Minocycline

2.74

(1.54 to 7.82)

−0.23

(−1.09 to 0.23)

0.33

(−1.44 to 1.29)

1.65

(1.01 to 1.97)

Oral

Ciprofloxacin

2.99

(1.86 to 5.23)

−0.63

(−1.21 to 0.19)

0.19

(−0.85 to 0.96)

1.56

(0.84 to –1.96)

Clindamycin

3.56

(2.33 to 5.77)

−0.73

(−1.44 to 0.14)

0.66

(−0.33 to 1.37)

1.61

(1.02 to 1.96)

Amoxicillin

4.24

(0.41 to 9.26)

−0.13

(−1.01 to 0.71)

−1.58

(−1.96 to 0.46)

−0.33

(−1.45 to 1.69)

Minocycline

3.38

(0.70 to 8.85)

0.53

(−0.50 to 1.55)

−0.73

(−1.87 to 1.19)

1.27

(−0.63 to 1.94)

  1. Results from Bayesian fitting of the full model (model 2, Eq. 4) to each of the eight possible treatment groups (four antibiotics × two microbiomes)